Angiopoietin-2, its soluble receptor tie-2 and subclinical cardiovascular disease in a population-based sample

Heart

Volumn 101, Issue 3, 2015, Pages 178-184

  Lorbeer, Roberto ^a   Baumeister, Sebastian E ^a   Dörr, Marcus ^b,c   Felix, Stephan B ^b,c   Nauck, Matthias ^c,d   Grotevendt, Anne ^d   Markus, Marcello R P ^a   Von Sarnowski, Bettina ^e   Völzke, Henry ^a,c   Vasan, Ramachandran S ^f   Wallaschofski, Henri ^c,d   Lieb, Wolfgang ^g,h  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b Department of Internal Medicine ^*  (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d Institute of Clinical Chemistry and Laboratory Medicine   (Germany)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF KIEL   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL PERMEABILITY; BODY MASS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FLOW MEASUREMENT; FLOW MEDIATED DILATION; FOLLOW UP; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORPHOLOGY; POPULATION RESEARCH; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; BLOOD; CARDIOVASCULAR DISEASES; DISEASE COURSE; GERMANY; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RECEPTOR, TIE-2; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84920885438     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306056     Document Type: Article

References (28)

1. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006;312:630-41.
2. Ward NL, Dumont DJ. The angiopoietins and tie2/tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 2002;13:19-27.
3. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006;27:552-8.
4. Reusch P, Barleon B, Weindel K, et al. Identification of a soluble form of the angiopoietin receptor tie-2 released from endothelial cells and present in human blood. Angiogenesis 2001;4:123-31.
5. Findley CM, Mitchell RG, Duscha BD, et al. Plasma levels of soluble tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol 2008;52:387-93.
6. Chong AY, Caine GJ, Freestone B, et al. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol 2004;43:423-8.
7. Patel JV, Lim HS, Varughese GI, et al. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann Med 2008;40:215-22.
8. Lorbeer R, Baumeister SE, Dorr M, et al. Circulating angiopoietin-2, its soluble receptor tie-2, and mortality in the general population. Eur J Heart Fail 2013;15:1327-34.
9. Shroff RC, Price KL, Kolatsi-Joannou M, et al. Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLoS ONE 2013;8: e56273.
10. Lim HS, Lip GY, Blann AD. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to vegf, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 2005;180:113-18.
11. El-Banawy HS, Gaber EW, Maharem DA, et al. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus. J Nephrol 2012;25:541-50.
12. Eleuteri E, Di Stefano A, Tarro Genta F, et al . Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. Eur J Cardiovasc Prev Rehabil 2011;18:607-14.
13. Lukasz A, Beutel G, Kumpers P, et al. Angiopoietin-2 in adults with congenital heart disease and heart failure. PLoS ONE 2013;8:e66861.
14. Volzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in pomerania. Int J Epidemiol 2011;40:294-307.
15. Haring R, Volzke H, Vasan RS, et al. Sex-specific associations of serum prolactin concentrations with cardiac remodeling: Longitudinal results from the study of health pomerania (ship). Atherosclerosis 2012;221:570-6.
16. Lorbeer R, Empen K, Dorr M, et al. Association between glycosylated haemoglobin a(1c) and endothelial function in an adult non-diabetic population. Atherosclerosis 2011;217:358-63.
17. Troitzsch P, Paulista Markus MR, Dorr M, et al. Psoriasis is associated with increased intima-media thickness-the study of health in pomerania (ship). Atherosclerosis 2012;225:486-90.
18. von Sarnowski B, Ludemann J, Volzke H, et al. Common carotid intima-media thickness and framingham risk score predict incident carotid atherosclerotic plaque formation: Longitudinal results from the study of health in pomerania. Stroke 2010;41:2375-7.
19. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in Mmode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58(6):1072-83.
20. Gillett MJ. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
21. Haring R, Volzke H, Felix SB, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the study of health in pomerania. Diabetes 2009;58:2027-31.
22. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999;130:461-70.
23. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010;29:1037-57.
24. Lieb W, Zachariah JP, Xanthakis V, et al. Clinical and genetic correlates of circulating angiopoietin-2 and soluble tie-2 in the community. Circ Cardiovasc Genet 2010;3:300-6.
25. Friedrich N, Aumann N, Dorr M, et al. Lack of association between insulin-like growth factor-1 or insulin-like growth factor-binding protein-3 and left ventricular hypertrophy: Results of the study of health in pomerania. J Hypertens 2010;28:856-64.
26. Eklund L, Saharinen P. Angiopoietin signaling in the vasculature. Exp Cell Res 2013;319:1271-80.
27. Konttinen J, Lindholm H, Sinisalo J, et al. Association between lowered endothelial function measured by peripheral arterial tonometry and cardio-metabolic risk factors-a cross-sectional study of finnish municipal workers at risk of diabetes and cardiovascular disease. BMC Cardiovasc Disord 2013;13:83.
28. Panayiotou AG, Griffin M, Kouis P, et al. Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol Metab Syndr 2013;5:44.